494 related articles for article (PubMed ID: 31713950)
21. PrP(Sc) of scrapie 263K propagates efficiently in spleen and muscle tissues with protein misfolding cyclic amplification.
Shi S; Dong CF; Wang GR; Wang X; An R; Chen JM; Shan B; Zhang BY; Xu K; Shi Q; Tian C; Gao C; Han J; Dong XP
Virus Res; 2009 Apr; 141(1):26-33. PubMed ID: 19162101
[TBL] [Abstract][Full Text] [Related]
22. Critical significance of the region between Helix 1 and 2 for efficient dominant-negative inhibition by conversion-incompetent prion protein.
Taguchi Y; Mistica AM; Kitamoto T; Schätzl HM
PLoS Pathog; 2013; 9(6):e1003466. PubMed ID: 23825952
[TBL] [Abstract][Full Text] [Related]
23. Semisynthesis of membrane-attached prion proteins.
Chu NK; Becker CF
Methods Enzymol; 2009; 462():177-93. PubMed ID: 19632475
[TBL] [Abstract][Full Text] [Related]
24. Generation of genuine prion infectivity by serial PMCA.
Weber P; Giese A; Piening N; Mitteregger G; Thomzig A; Beekes M; Kretzschmar HA
Vet Microbiol; 2007 Aug; 123(4):346-57. PubMed ID: 17493773
[TBL] [Abstract][Full Text] [Related]
25. Identifying critical sites of PrP(c)-PrP(Sc) interaction in prion-infected cells by dominant-negative inhibition.
Taguchi Y; Schätzl HM
Prion; 2013; 7(6):452-6. PubMed ID: 24401595
[TBL] [Abstract][Full Text] [Related]
26. Neurometals in the Pathogenesis of Prion Diseases.
Kawahara M; Kato-Negishi M; Tanaka KI
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33525334
[TBL] [Abstract][Full Text] [Related]
27. Discriminating between cellular and misfolded prion protein by using affinity to 9-aminoacridine compounds.
Phuan PW; Zorn JA; Safar J; Giles K; Prusiner SB; Cohen FE; May BCH
J Gen Virol; 2007 Apr; 88(Pt 4):1392-1401. PubMed ID: 17374787
[TBL] [Abstract][Full Text] [Related]
28. Determinants of the in vivo folding of the prion protein. A bipartite function of helix 1 in folding and aggregation.
Winklhofer KF; Heske J; Heller U; Reintjes A; Muranyi W; Moarefi I; Tatzelt J
J Biol Chem; 2003 Apr; 278(17):14961-70. PubMed ID: 12556465
[TBL] [Abstract][Full Text] [Related]
29. Prion protein functions and dysfunction in prion diseases.
Sakudo A; Ikuta K
Curr Med Chem; 2009; 16(3):380-9. PubMed ID: 19149584
[TBL] [Abstract][Full Text] [Related]
30. A seven-residue deletion in PrP leads to generation of a spontaneous prion formed from C-terminal C1 fragment of PrP.
Munoz-Montesino C; Larkem D; Barbereau C; Igel-Egalon A; Truchet S; Jacquet E; Nhiri N; Moudjou M; Sizun C; Rezaei H; Béringue V; Dron M
J Biol Chem; 2020 Oct; 295(41):14025-14039. PubMed ID: 32788216
[TBL] [Abstract][Full Text] [Related]
31. [Mechanisms of prion transmission].
Sakaguchi S
Nihon Rinsho; 2007 Aug; 65(8):1391-5. PubMed ID: 17695274
[TBL] [Abstract][Full Text] [Related]
32. Heterogeneity and Architecture of Pathological Prion Protein Assemblies: Time to Revisit the Molecular Basis of the Prion Replication Process?
Igel-Egalon A; Bohl J; Moudjou M; Herzog L; Reine F; Rezaei H; Béringue V
Viruses; 2019 May; 11(5):. PubMed ID: 31083283
[TBL] [Abstract][Full Text] [Related]
33. Differential solubility of prions is associated in manifold phenotypes.
Kuczius T; Karch H; Groschup MH
Mol Cell Neurosci; 2009 Nov; 42(3):226-33. PubMed ID: 19607920
[TBL] [Abstract][Full Text] [Related]
34. Altered prion protein glycosylation in the aging mouse brain.
Goh AX; Li C; Sy MS; Wong BS
J Neurochem; 2007 Feb; 100(3):841-54. PubMed ID: 17144900
[TBL] [Abstract][Full Text] [Related]
35. Molecular biology and pathology of prion strains in sporadic human prion diseases.
Gambetti P; Cali I; Notari S; Kong Q; Zou WQ; Surewicz WK
Acta Neuropathol; 2011 Jan; 121(1):79-90. PubMed ID: 21058033
[TBL] [Abstract][Full Text] [Related]
36. Sheep scrapie susceptibility-linked polymorphisms do not modulate the initial binding of cellular to disease-associated prion protein prior to conversion.
Rigter A; Bossers A
J Gen Virol; 2005 Sep; 86(Pt 9):2627-2634. PubMed ID: 16099922
[TBL] [Abstract][Full Text] [Related]
37. Formation of native prions from minimal components in vitro.
Deleault NR; Harris BT; Rees JR; Supattapone S
Proc Natl Acad Sci U S A; 2007 Jun; 104(23):9741-6. PubMed ID: 17535913
[TBL] [Abstract][Full Text] [Related]
38. Does the tail wag the dog? How the structure of a glycosylphosphatidylinositol anchor affects prion formation.
Bate C; Nolan W; Williams A
Prion; 2016 Mar; 10(2):127-30. PubMed ID: 26901126
[TBL] [Abstract][Full Text] [Related]
39. DNA converts cellular prion protein into the beta-sheet conformation and inhibits prion peptide aggregation.
Cordeiro Y; Machado F; Juliano L; Juliano MA; Brentani RR; Foguel D; Silva JL
J Biol Chem; 2001 Dec; 276(52):49400-9. PubMed ID: 11604397
[TBL] [Abstract][Full Text] [Related]
40. The octarepeat region of the prion protein is conformationally altered in PrP(Sc).
Yam AY; Gao CM; Wang X; Wu P; Peretz D
PLoS One; 2010 Feb; 5(2):e9316. PubMed ID: 20195363
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
